Dossier
Vitas Healthcare
Coverage of Vitas Healthcare in the Nexus archive.
- Chemed: Q2 Earnings Snapshot
Chemed Corp. reported Q2 net income of $67.7 million, or $5.13 per share, with adjusted earnings of $6.06 per share. The company generated $673.3 million in revenue and expects full-year earnings between $25 and $25.75 per share.